Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v8-FR
Language French French
Date Updated 2018-07-20 2018-07-09
Drug Identification Number 02323060 02323060
Brand name INSPRA INSPRA
Common or Proper name INSPRA INSPRA
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients EPLERENONE EPLERENONE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 3 x 10 TABS 3 x 10 TABS
ATC code C03DA C03DA
ATC description POTASSIUM-SPARING AGENTS POTASSIUM-SPARING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-07-09 2018-07-09
Estimated end date 2018-08-03
Actual end date 2018-07-19
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments On preventative allocation until supply depletion.
Health Canada comments